WASHINGTON — Congress gave the Food and Drug Administration a clear directive to crack down on vape companies skirting the agency’s rules. But there are growing signs the agency is not ready to do as instructed.
Now, advocates are apoplectic.
About the Author Reprints
Create a display name to comment
This name will appear with your comment
